In October 2026, Hongmili China Lipid Patient Network was shortlisted for the 2026 Global Heart Hub Unite Summit Global Excellence Award!Homy FH China Patient NetworkTitle of the Project/ Initiativ...

Setting OffAt the break of dawn on October 11, 2026, the team from Hongmili Mutual Aid House flew from Xi'an, Shaanxi to Nanjing, Jiangsu with their interview equipment. Their mission was to visual...

Focusing on rare dyslipidemia, building a patient support network-HoFH/FCS Patient Advocacy Workshop was successfully held in Beijing·Preface ·On September 18-19, 2026, the "2026 China HoFH Patient...

· 24 September：FH Awareness Day  ·Familial hypercholesterolemia (FH) is an autosomal inherited disease caused by a mutation in one of the key genes involved in the catabolism of low-density lipopro...

On September 18, 2026, the "2026 China HoFH Patient Survival Status Survey Report," initiated by Hongmili Mutual Aid Home and jointly completed with the team of Director Zhuang Tian  of the Departm...

The Launch Event for the "2026 China HoFH Patient Survival Status Survey Report" was successfully held in Beijing! With real data as a bridge,Let the plight of 122 families be seenOn September 18,2...

The fund plans to support the  10 projects, including 4 in basic research, 5 in clinical and epidemiological research, and 1 in advanced therapy development.

Delayed diagnosis is a common challenge faced by patients with homozygous familial hypercholesterolemia (HoFH). Due to the rarity of the disease, limited awareness at the primary healthcare level, ...

From September 19 to 21, 2025, the inaugural Familial Hypercholesterolemia (FH) Conference and Patient Exchange Meeting, initiated and hosted by the Homy FH China Patient Network with collaborative...

Following the successful conclusion of The 1st Chinese Conference on Familial Hypercholesterolemia on September 20, FH China Patient Network thoughtfully planned a warm and heartfelt city tour of W...